Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
1-Minute Consult

Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?

Nicholas B. Cline, MD, Amudha Pazhanisamy, DO and David M. Lang, MD
Cleveland Clinic Journal of Medicine March 2025, 92 (3) 147-151; DOI: https://doi.org/10.3949/ccjm.92a.24054
Nicholas B. Cline
The Allergy, Asthma, and Sinus Center, Harriman, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amudha Pazhanisamy
Department of Allergy and Clinical Immunology, Medical Specialty Institute, Cleveland Clinic, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David M. Lang
Department of Allergy and Clinical Immunology, Medical Specialty Institute, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Find this author on Cleveland Clinic
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1

    Chemical structures of antimicrobial and nonantimicrobial sulfonamides. Interclass reactivity and nonreactivity between antimicrobial and nonantimicrobial sulfonamides are shown. All sulfonamides contain an SO2NH2 an arylamine group at the N4 position (arrow), which serves as the primary target for immunoglobulin E–moiety. Antimicrobial sulfonamides (eg, sulfamethoxazole and sulfanilamide) contain mediated sensitization. Nonantimicrobial sulfonamides (eg, celecoxib, chlorothiazide, and furosemide) lack the arylamine group at the N4 position. For this reason, these drugs do not cross-react with antimicrobial sulfonamides.

Tables

  • Figures
    • View popup
    TABLE 1

    Gell and Coombs classification of hypersensitivity reactions

    TypeHypersensitivity reactionImmune mechanismDescription
    IImmediate hypersensitivityImmunoglobulin E–mediated reaction driven by immunoglobulin E bound to mast cells or basophils or bothEngagement of immunoglobulin E with its appropriate antigen leads to degranulation and release of histamine, leukotrienes, and other inflammatory mediators (eg, anaphylaxis)
    IICytotoxic antibodyAntigen-antibody interactionLocal production of anaphylatoxin (C5a) and recruitment of polymorphonuclear leukocytes lead to release of hydrolytic neutrophil enzymes and subsequent tissue injury (eg, immune cytopenia)
    IIIImmune complexImmunoglobulin G and M antibodies bind to antigenAntigen-antibody complexes deposit in the glomerular basement membrane, pulmonary basement membrane, or both, leading to tissue injury and organ damage (eg, serum sickness reaction)
    IVDelayed hypersensitivityCell-mediated immune responseT cells are activated by an antigen-presenting cell; when antigen is presented again, memory T cells activate leukocytes (macrophages, neutrophils, eosinophils), leading to an inflammatory response with possible tissue injury via reactive oxygen species, lysosomal enzymes, and inflammatory cytokines (eg, tuberculin skin test, Rhus dermatitis, Stevens-Johnson syndrome or toxic epidermal necrolysis)
    • View popup
    TABLE 2

    Commonly prescribed antimicrobial and nonantimicrobial sulfonamides

    AntimicrobialNonantimicrobial
    ClassExamples
    Sulfacetamide
    Sulfadiazine
    Sulfamerazine
    Sulfamethoxazole
    Sulfanilamide
    Sulfapyridine
    Sulfasalazine
    Sulfathiazole
    Carbonic anhydrase inhibitorsAcetazolamide
    Cyclooxygenase-2 inhibitorsCelecoxib
    Loop diureticsBumetanide
    Furosemide
    Torsemide
    SulfonylureasGlipizide
    Glyburide
    Thiazide diureticsHydrochlorothiazide
    Chlorthalidone
    TriptansRizatriptan
    Sumatriptan
    MiscellaneousDiazoxide
    Tamsulosin
    Zonisamide
    Metolazone
    Probenecid
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 92 (3)
Cleveland Clinic Journal of Medicine
Vol. 92, Issue 3
1 Mar 2025
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
Nicholas B. Cline, Amudha Pazhanisamy, David M. Lang
Cleveland Clinic Journal of Medicine Mar 2025, 92 (3) 147-151; DOI: 10.3949/ccjm.92a.24054

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can my patient with a ‘sulfa allergy’ receive celecoxib or other nonantimicrobial sulfonamides?
Nicholas B. Cline, Amudha Pazhanisamy, David M. Lang
Cleveland Clinic Journal of Medicine Mar 2025, 92 (3) 147-151; DOI: 10.3949/ccjm.92a.24054
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • SULFONAMIDE ALLERGY
    • CROSS-REACTIVITY BETWEEN SULFONAMIDES
    • EVALUATION AND MANAGEMENT OF SULFONAMIDE ALLERGY
    • THE BOTTOM LINE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • All sulfa drugs are not created equal
  • Google Scholar

More in this TOC Section

  • What diagnostic tests should be done after discovering clubbing in a patient without cardiopulmonary symptoms?
  • Does my adult patient need a measles vaccine?
  • Do I need to treat supine hypertension in my hospitalized patient?
Show more 1-Minute Consult

Similar Articles

Subjects

  • Allergy/Immunology
  • Rheumatology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire